Search Result "vWF"
Mutations and Common Polymorphisms in ADAMTS13 and vWF Genes Responsible for Increasing Risk of Thrombosis
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18 Issue: 3 Year: 2018 Page: 176-181
Author(s): Habib Haybar,Elahe Khodadi,Maria Kavianpour,Najmaldin Saki
Structure and Function of the Von Willebrand Factor A1 Domain
Journal: Current Protein & Peptide Science
Volume: 3 Issue: 3 Year: 2002 Page: 301-312
Author(s): Kottayil I. Varughese, Reha Celikel, Zaverio M. Ruggeri
Von Willebrand Factor: Drug and Drug Target
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 9-20
Author(s): Simon F. De Meyer, Bauke De Maeyer, Hans Deckmyn, Karen Vanhoorelbeke
von Willebrand Factor, von Willebrand Factor-Cleaving Protease, and Shear Stress
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 4 Year: 2007 Page: 305-310
Author(s): P. Perutelli, A. C. Molinari
Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 5 Year: 2017 Page: 404-415
Author(s): Felice Gragnano,Enrica Golia,Francesco Natale,Renatomaria Bianchi,Ivana Pariggiano,Mario Crisci,Vincenzo Diana,Fabio Fimiani,Giuseppe Limongelli,Mariagiovanna Russo,Plinio Cirillo,Paolo Calabrò
Thrombospondin-1 in Von Willebrand Factor Function
Journal: Current Drug Targets
Volume: 9 Issue: 1 Year: 2008 Page: 822-832
Author(s): Arnaud Bonnefoy, Marc F. Hoylaerts
Molecular Link between Intravascular Hemolysis and Vascular Occlusion in Sickle Cell Disease
Journal: Current Vascular Pharmacology
Volume: 10 Issue: 6 Year: 2012 Page: 756-761
Author(s): Zhou Zhou,Donald L. Yee,Prasenjit Guchhait
Von Willebrand Factor and Thrombosis: Risk Factor, Actor and Pharmacological Target
Journal: Current Vascular Pharmacology
Volume: 11 Issue: 4 Year: 2013 Page: 448-456
Author(s): Peter J. Lenting, Cecile V. Denis, Nikolett Wohner
Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism
Journal: Current Vascular Pharmacology
Volume: 13 Issue: 2 Year: 2015 Page: 192-201
Author(s): Yutao Guo,Gregory Y.H. Lip,Stavros Apostolakis
Development of Monoclonal Antibodies that Inhibit Platelet Adhesion or Aggregation as Potential Anti-Thrombotic Drugs
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 6 Issue: 3 Year: 2006 Page: 191-207
Author(s): S. F. De Meyer, K. Vanhoorelbeke, H. Ulrichts, S. Staelens, H. B. Feys, I. Salles, A. Fontayne, H. Deckmyn